Prevalence of metilentetrahidrofolate reductase C677T polymorphism, consumption of vitamins B6, B9, B12 and determination of lipidic hydroperoxides in obese and normal weight mexican population;Prevalencia del polimorfismo C677T de la metilentetrahidrofolato reductasa, consumo de las vitaminas B6, B9, B12 y determinación de hidroperóxidos lipídicos en población mexicana obesa y con peso normal

Nutricion Hospitalaria

Volumn 28, Issue 6, 2013, Pages 2142-2150

  Hernández Guerrero, César ^a   Romo Palafox, Inés ^a   Díaz Gutiérrez, Mary Carmen ^a   Iturbe García, Mariana ^a   Texcahua Salazar, Alejandra ^a   Pérez Lizaur, Ana Bertha ^a  

^a UNIVERSIDAD IBEROAMERICANA   (Mexico)

Author keywords

Lipid hydroperoxide; MTHFR C677T polymorphism; Obesity; Oxidative stress; Vitamins

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; LIPID PEROXIDE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PYRIDOXINE;

ADOLESCENT; ADULT; BLOOD; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MEXICO; MIDDLE AGED; OBESITY; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; FOLIC ACID; GENE FREQUENCY; HUMANS; LIPID PEROXIDES; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PREVALENCE; VITAMIN B 12; VITAMIN B 6; YOUNG ADULT;

EID: 84891667149     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.6.6902     Document Type: Article

References (30)

1. Orzano A, Scott J. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 2004; 17: 359-69.
2. World Heath Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation. WHO Technical Report Series. Geneva; 2000.
3. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, López P, Hernández M, Tapia R, Sepúlveda J. Encuesta Nacional de Salud 2000. Tomo 2. Cuernavaca, México: Instituto Nacional de Salud Pública.
4. Gutierrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernandez S, Franco A, Cuevas-Nasu L, Romero- Martinez M, Hernandez-Avila M. Encuesta Nacional de Salud y Nutricion 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Publica (MX), 2012.
5. Secretaría de Salud. Dirección General de Información en Salud. Causas de muerte según códigos de la Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima Revisión (CIE- N). Consejo Nacional de Población. México, 2006.
6. Kennedy DA, Stern SJ, Matik I, Moretti ME, Sarkar M, Adams- Webber T et al. Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta- Analysis. J Cancer Epidemiol 2012. pp. 1-24.
7. Cardona H, Cardona-Maya W, Gómez JG, Castañeda S, Gómez JM, Bedoya G et al. Relación entre los polimorfismos de la metilen-tetrahidrofotato-reductasa y los niveles de homocisteína en mujeres con pérdida gestacional recurrente: perspective desde la nutrigenética. Nutr Hosp 2008; 23 (3): 277-82.
8. Sánchez C, Planells E, Aranda P, Pérez de la Cruz A, Asensio C, Mataix J et al. Vitaminas B y homocisteína en la insuficiencia renal crónica. Nutr Hosp 2007; 22 (6): 661-71.
9. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996; 98: 5-7.
10. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 2006; 30: 400-18.
11. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 26 (22): 12810-5.
12. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willet W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City*. Instituto Nacional de Salud Pública 1998; 40 (2): 133-40.
13. Jiang Z-Y, Hunt JV, Wolff SP. Ferrous Ion Oxidation in the Presence of Xylenol Orange for Detection of Lipid Hydroperoxide in Low Density Lipoprotein. Anal Biochem 1992; 202: 384-9.
14. Dávalos I-P, Olivares N, Castillo M-T, Cantú J-M, Ibarra B, Sandoval L et al. The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neuraltube defect parents, control mestizo and native populations. Ann. Genet 2000; 43: 89-92.
15. Mutchinichk OM, López MA, Luna L, Waxman J, Babinsky VE. High Prevalence of the Thermolabile Methylenetetrahydrofolate Reductase Variant in Mexico: A Country with a Very High Prevalence of Neural Tube Defects. Mol Genet Metab 1999; 68: 461-7.
16. Guéant-Rodríguez RM, Guéant JL, Debard R, Thirion S, Hong LX, Bronowicki JP et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006; 83: 701-7.
17. Terruzzi I, Senesi P, Fermo I, Lattuada G, Luzi L. Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity? J Endocrinol Invest 2007; 30 (9): 747-53.
18. Settin AA, Algasham A, Dowaidar M, Ismail H. Methylene tetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms related to overweight/obesity among Saudi subjects from Qassim Region. Dis Markers 2009; 27: 97-102.
19. Yin R-X, Wu D-F, Miao L, Htet Htet Aung L, Cao X-L, Yan TT et al. Several genetic polymorphisms interact with overweight/ obesity to influence serum lipid levels. Cardiovasc Diabetol 2012; 11: 123.
20. Liu X, Zhao L-J, Liu Y-J, Xiong D-H, Recker RR, Deng H-W. The MTHFR gene polymorphism is associated with lean body mass but not fat body mass. Hum Genet 2008; 123: 189-96.
21. Chauhan G, Kaur I, Tabassum R, Om Prakash Dwivedi, Ghosh S, Tandon N et al. F Variants of Homocysteine Metabolism Pathway Genes and Risk of Type 2 Diabetes and Related Traits in Indians. Exp Diabetes Res 2012. pp. 1-7.
22. AbdRaboh NR, Badr S, Ali S. Prevalence of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Egyptian patients with type 2 diabetes mellitus. Egypt J Med Hum Genet 2013; 14: 87-93.
23. Varela-Moreiras G, Escudero, JM, Alonso-Aperte E. Homocisteína, vitaminas relacionadas y estilos de vida en personas de edad avanzada: estudio SÉNECA. Nutr Hosp 2007; 22 (3): 363-70.
24. Bayo MP, Olivares López MJ, Osuna Ortega A, Peinado A, Quesada Granados JJ, López García de la Serrana H, et al. Resistencia de la hiperhomocisteinemia del paciente renal al tratamiento con dosis suprafisiológicas de ácido fólico parenteral. Nutr Hosp 2008; 23 (3): 268-76.
25. Mojtabai R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol 2004; 19 (11): 1029-36.
26. Hirsch S, Poniachick J, Avendaño M, Csendes A, Burdiles P, Smok G, et al. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition 2005; 21 (2): 137-41.
27. Kimi Uehara S, Rosa G. Association of uricemia with biochemical and dietary factors in human adults with metabolic syndrome genotyped to C677T polymorphism in the methylenetetrahydrofolate reductase gene. Nutr Hosp 2011; 26 (2): 298-303.
28. Ruano Gil M, Teruel S, Aguirregoicoa Garcia E, Criado Gomez L, Duque Lopez Y, Garcia-Blanch G. Nutrición, síndrome metabólico y obesidad mórbida. Nutr Hosp 2011; 26 (4): 759-64.
29. Spinneker A, Sola R, Lemmen V, Castillo MJ, Pietrzik K, Gonzalez-Gross M. Vitamin B6 status, deficiency and its consequences - an overview. Nutr Hosp 2007; 22 (1): 7-24.
30. Al-Tahan J, González-Gross M, Pietrzik K. B-Vitamin status and intake in European adolescents. A review of the literature. Nutr Hosp 2006; 21 (4): 452-65.